Form 4: Marlene Colucci Reports QXO Stock Transactions
Insider Transaction Report
Marlene Colucci, a Director at QXO, Inc., reported transactions involving restricted stock units and common stock on May 5, 2026.
Summary
- Marlene Colucci, a Director at QXO, Inc., reported the acquisition of 9,274 Restricted Stock Units (RSUs) and the disposition of 12,111 shares of Common Stock on May 5, 2026.
- The RSUs acquired are subject to vesting conditions tied to the Issuer's 2027 Annual Meeting of Stockholders, contingent on continued service as a director.
- Previously granted RSUs, awarded on May 12, 2025, vested and settled in full on the date of the Issuer's 2026 Annual Meeting of Stockholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, reflecting standard insider transactions with both acquisitions and dispositions of equity, without clear indicators of significant positive or negative shifts in insider confidence.
Positives
- Director Marlene Colucci acquired 9,274 Restricted Stock Units, indicating continued equity-based compensation and potential future ownership.
- The acquisition of RSUs suggests management confidence in the company's future prospects, as these units are tied to future vesting and performance.
Negatives
- Director Marlene Colucci disposed of 12,111 shares of Common Stock, which could be interpreted as a reduction in direct ownership.
Risks
- The vesting of the newly acquired RSUs is contingent upon Marlene Colucci's continued service as a director through the Issuer's 2027 Annual Meeting of Stockholders, posing a risk if her tenure ends prematurely.
- The disposition of 12,111 shares of Common Stock by a director could be perceived negatively by the market, although the context of the transaction is not fully detailed.
Future Outlook
The future outlook for the acquired RSUs is tied to the company's performance and Marlene Colucci's continued service as a director, with full vesting expected by the Issuer's 2027 Annual Meeting of Stockholders.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. Such filings are crucial for investors seeking to understand insider sentiment and potential shifts in beneficial ownership.
Stakeholder Impact
- Shareholders: The disposition of shares by a director may raise questions about their outlook, while the acquisition of RSUs indicates continued equity-based compensation and potential future shareholding.
- Employees: The transaction is primarily related to director compensation and does not directly indicate immediate impact on general employee compensation or roles.
- Management: The transaction reflects standard compensation practices for directors and does not suggest any immediate changes in executive strategy or operations.
Next Steps
- Marlene Colucci's continued service as a director is required for the full vesting of the 9,274 RSUs by the Issuer's 2027 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Transaction Date for acquisition of RSUs and disposition of Common Stock. |
| 05/07/2026 | Date of signature for the filing. |
| 05/12/2025 | Date of grant for previously awarded RSUs. |
| 2026 | Year of the Issuer's Annual Meeting of Stockholders where previously awarded RSUs vested and settled. |
| 2027 | Year of the Issuer's Annual Meeting of Stockholders, by which date newly acquired RSUs are set to vest. |
Keywords
Form 4, SEC Filing, Insider Trading, Stock Transaction, Restricted Stock Units, Common Stock, QXO Inc., Marlene Colucci, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.